Therapeutic targeting of transcription in acute promyelocytic leukemia by use of an inhibitor of histone deacetylase

被引:471
作者
Warrell, RP
He, LZ
Richon, V
Calleja, E
Pandolfi, PP
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Med, Dev Chemotherapy & Leukemia Serv, New York, NY 10021 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Human Genet, New York, NY 10021 USA
[3] Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10021 USA
[4] Mem Sloan Kettering Canc Ctr, Cell Biol Program, New York, NY 10021 USA
[5] Mem Sloan Kettering Canc Ctr, Dept Pediat, New York, NY 10021 USA
[6] Cornell Univ, Coll Med, New York, NY 10021 USA
来源
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE | 1998年 / 90卷 / 21期
关键词
D O I
10.1093/jnci/90.21.1621
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Acetylation of DNA-associated histones is linked to activation of gene transcription, whereas histone deacetylation is associated with transcriptional repression. Recent studies have shown that inhibitors of histone deacetylases can relieve transcriptional repression caused by the products of certain oncogenes, We tested whether these findings could be applied clinically to a patient with highly resistant acute promyelocytic leukemia. Methods: A patient who had experienced multiple relapses was treated with all-trans-retinoic acid alone and in combination with sodium phenylbutyrate, an inhibitor of histone deacetylases. Immunohistochemistry and western blot analysis were used to assay for histone hyperacetylation in mononuclear cells from the patient's blood and bone marrow. Marrow mononuclear cells and reverse transcription-polymerase chain reaction (RT-PCR) analysis of messenger RNA encoded by the PML/RAR-alpha oncogene were used to assess minimal residual disease. Results: The patient proved clinically resistant to treatment with all-trans-retinoic acid alone. However, 23 days after sodium phenylbutyrate was added to the treatment regimen, visible leukemic cells had been eliminated from her bone marrow, and she achieved a complete clinical and cytogenetic remission shortly thereafter. With a second treatment course, analysis for minimal residual disease by RT-PCR proved negative, Immunofluorescence and western blot analysis showed that phenylbutyrate caused a time-dependent increase in histone acetylation in blood and bone marrow mononuclear cells. Conclusions: Clinical treatment with an inhibitor of histone deacetylase induces histone hyperacetylation in target cells and may restore sensitivity to the anti-leukemic effects of all-trans-retinoic acid in acute promyelocytic leukemia. Similar therapy may prove useful in other neoplastic diseases that are associated with oncogenic repression of gene transcription due to recruitment of histone deacetylases.
引用
收藏
页码:1621 / 1625
页数:5
相关论文
共 39 条
  • [1] Role for N-CoR and histone deacetylase in Sin3-mediated transcriptional repression
    Alland, L
    Muhle, R
    Hou, H
    Potes, J
    Chin, L
    SchreiberAgus, N
    DePinho, RA
    [J]. NATURE, 1997, 387 (6628) : 49 - 55
  • [2] ANDREEFF M, 1992, BLOOD, V80, P2604
  • [3] MAD-MAX TRANSCRIPTIONAL REPRESSION IS MEDIATED BY TERNARY COMPLEX-FORMATION WITH MAMMALIAN HOMOLOGS OF YEAST REPRESSOR SIN3
    AYER, DE
    LAWRENCE, QA
    EISENMAN, RN
    [J]. CELL, 1995, 80 (05) : 767 - 776
  • [4] The CBP co-activator is a histone acetyltransferase
    Bannister, AJ
    Kouzarides, T
    [J]. NATURE, 1996, 384 (6610) : 641 - 643
  • [5] The translocation t(8;l6)(p11, p13) of acute myeloid leukaemia fuses a putative acetyltransferase to the CREB binding protein
    Borrow, J
    Stanton, VP
    Andresen, JM
    Becher, R
    Behm, FG
    Chaganti, RSK
    Civin, CI
    Disteche, C
    Dube, I
    Frischauf, AM
    Horsman, D
    Mitelman, F
    Volinia, S
    Watmore, AE
    Housman, DE
    [J]. NATURE GENETICS, 1996, 14 (01) : 33 - 41
  • [6] SODIUM BUTYRATE INHIBITS HISTONE DEACETYLATION IN CULTURED-CELLS
    CANDIDO, EPM
    REEVES, R
    DAVIE, JR
    [J]. CELL, 1978, 14 (01) : 105 - 113
  • [7] CARDUCCI M, 1998, P AM SOC CLIN ONCOL, V17, pA215
  • [8] CASTAIGNE S, 1990, BLOOD, V76, P1704
  • [9] A TRANSCRIPTIONAL CO-REPRESSOR THAT INTERACTS WITH NUCLEAR HORMONE RECEPTORS
    CHEN, JD
    EVANS, RM
    [J]. NATURE, 1995, 377 (6548) : 454 - 457
  • [10] THE T(15-17) TRANSLOCATION OF ACUTE PROMYELOCYTIC LEUKEMIA FUSES THE RETINOIC ACID RECEPTOR-ALPHA GENE TO A NOVEL TRANSCRIBED LOCUS
    DETHE, H
    CHOMIENNE, C
    LANOTTE, M
    DEGOS, L
    DEJEAN, A
    [J]. NATURE, 1990, 347 (6293) : 558 - 561